Get started
Author

Mario Rosario D'Andrea

Observed names: D’Andrea, Mario Rosario, M D'Andrea, M. D'Andrea, M. Dandrea, M.R. D'Andrea, Mario D'Andrea, Mario D’Andrea, Mario R. D'Andrea, Mario R. D’Andrea, Mario Rosario D'andrea, Mario Rosario D’Andrea, Mario Rosario D��Andrea
Institution: ASL Roma
Observed institutions: University of Verona, Universidad Complutense de Madrid, University of Sannio, Policlinico Umberto I, University of Chicago, Ospedale San Paolo, Ospedale San Paolo, ASL Roma, Ospedale San Filippo Neri, Istituto Oncologico Veneto, Azienda Ospedaliera Santa Maria Degli Angeli, Centro di Riferimento Oncologico, National Cancer Institute, Ca' Foncello Hospital, Ospedale Civile di Vittorio Veneto, University of Florence, University of Naples Federico II, Sapienza University of Rome
ORCID: 0000-0003-4585-7473
Observed ORCID: 0000-0003-4585-7473
OpenAlex ID: A5074801254
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
2023 · Jesse J Swen, Cathelijne H van der Wouden, et al. · The Lancet · 559
PDF
The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer
2006 · Giuseppe Toffoli, Erika Cecchin, et al. · Journal of Clinical Oncology · 338
PDF
Oxaliplatin-related neurotoxicity: How and why?
2006 · Lara Maria Pasetto, Mario Rosario D’Andrea, et al. · Critical Reviews in Oncology/Hematology · 267
Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan
2009 · Erika Cecchin, Federico Innocenti, et al. · Journal of Clinical Oncology · 215
PDF
Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
2009 · Giuseppe Toffoli, Erika Cecchin, et al. · Journal of Clinical Oncology · 169
The development of platinum compounds and their possible combination
2006 · Lara Maria Pasetto, Mario Rosario D’Andrea, et al. · Critical Reviews in Oncology/Hematology · 109
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
2017 · Guido Giordano, Massimo Pancione, et al. · World Journal of Gastroenterology · 90
PDF
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
2019 · Elena De Mattia, Erika Cecchin, et al. · World Journal of Gastroenterology · 82
PDF
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
2012 · E Cecchin, M D'Andrea, et al. · The Pharmacogenomics Journal · 79
PDF
Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis
2006 · Mario R. D’Andrea, Maria R. Limiti, et al. · Breast Cancer Research and Treatment · 59
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
2018 · Giuseppe Toffoli, Federico Innocenti, et al. · Clinical Pharmacology & Therapeutics · 54
Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment
2013 · Elena De Mattia, Giuseppe Toffoli, et al. · Pharmacogenetics and Genomics · 54
JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
2019 · Guido Giordano, Pietro Parcesepe, et al. · Journal of Experimental & Clinical Cancer Research · 47
PDF
HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment
2015 · Marica Garziera, Ettore Bidoli, et al. · PLoS ONE · 33
PDF
Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab
2010 · Raffaele Longo, Mario D'Andrea, et al. · Expert Opinion on Investigational Drugs · 29
Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancer
2022 · Francesca Pia Caruso, Mario Rosario D’Andrea, et al. · Cancer Cell International · 25
PDF
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients
2019 · Adrien Labriet, Éric Lévesque, et al. · Scientific Reports · 25
PDF
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer
2024 · Rossana Roncato, Alessia Bignucolo, et al. · JAMA Network Open · 24
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
2014 · E Cecchin, G Perrone, et al. · The Pharmacogenomics Journal · 22
Clinical Usefulness of Bisphosphonates in Oncology: Treatment of Bone Metastases, antitumoral Activity and Effect on Bone Resorption Markers
2007 · A. Verì, M.R. D'Andrea, et al. · The International Journal of Biological Markers · 22
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
2018 · Elena De Mattia, Erika Cecchin, et al. · Frontiers in Pharmacology · 19
PDF
Gemcitabine in advanced biliary tract cancers
2006 · Lara Maria Pasetto, Mario Rosario D’Andrea, et al. · Critical Reviews in Oncology/Hematology · 19
Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era
2021 · Guido Giordano, Pietro Parcesepe, et al. · International Journal of Molecular Sciences · 17
PDF
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI
2019 · Elena De Mattia, Jerry Polesel, et al. · Frontiers in Oncology · 16
PDF
Fine Needle Aspiration Cytology of Squamous Cell Carcinoma Arising in a Thyroglossal Duct Cyst
1996 · Ersilia Ranieri, Mario Rosario D’Andrea, et al. · Acta Cytologica · 16
Works count: 70
Citation count: 2,581
H-index: 20
I10-index: 33
Year
Topic
Type